Cargando…

Performance Evaluation of Montelukast Pediatric Formulations: Part II — a PBPK Modelling Approach

This study aimed to build a physiologically based pharmacokinetic (PBPK) model coupled with age-appropriate in vitro dissolution data to describe drug performance in adults and pediatric patients. Montelukast sodium was chosen as a model drug. Two case studies were investigated: case study 1 focused...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guimarães, Mariana, Vertzoni, Maria, Fotaki, Nikoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816611/ https://www.ncbi.nlm.nih.gov/pubmed/35013803 http://dx.doi.org/10.1208/s12248-021-00662-1

Ejemplares similares

Performance Evaluation of Montelukast Pediatric Formulations: Part I—Age-Related In Vitro Conditions
por: Guimarães, Mariana, et al.
Publicado: (2022)

Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance Part 2: Dissolution of Montelukast Sodium and Mesalazine Formulations
por: Martir, J., et al.
Publicado: (2020)

Evaluating pediatric and adult simulated fluids solubility: Abraham solvation parameters and multivariate analysis
por: Guimarães, Mariana, et al.
Publicado: (2021)

Understanding the Impact of Age-Related Changes in Pediatric GI Solubility by Multivariate Data Analysis
por: Guimarães, Mariana, et al.
Publicado: (2022)

In Vivo Predictive Dissolution Testing of Montelukast Sodium Formulations Administered with Drinks and Soft Foods to Infants
por: Martir, J., et al.
Publicado: (2020)

Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet
por: Aslani, Abolfazl, et al.
Publicado: (2016)

Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets
por: Usmani, Muhammad Talha, et al.
Publicado: (2023)

Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating
por: Wiśniowska, Barbara, et al.
Publicado: (2022)

Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance: Part 1—Effects on Solubility of Poorly Soluble Drugs
por: Martir, J., et al.
Publicado: (2020)

Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
por: Kuepfer, L, et al.
Publicado: (2016)

Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation
por: Long, Chiau Ming, et al.
Publicado: (2019)

Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care
por: van der Heijden, Joyce E. M., et al.
Publicado: (2022)

Efficacy of montelukast for the treatment of pediatric allergic purpura
por: Bai, Li-ping, et al.
Publicado: (2019)

Developing a Formulation Strategy Coupled with PBPK Modeling and Simulation for the Weakly Basic Drug Albendazole
por: Shah, Harsh, et al.
Publicado: (2023)

Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast
por: Knorr, Barbara, et al.
Publicado: (2010)

In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part II
por: Witkowski, Jakub, et al.
Publicado: (2022)

Should we prescribe montelukast to allergic pediatric patients?
por: Park, Yong Mean
Publicado: (2020)

Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
por: Utembe, Wells, et al.
Publicado: (2020)

Editorial: Exploring Maternal-Fetal Pharmacology Through PBPK Modeling Approaches
por: Dallmann, André, et al.
Publicado: (2022)

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK
por: Wagner, C, et al.
Publicado: (2015)

PBPK modeling and simulation in drug research and development
por: Zhuang, Xiaomei, et al.
Publicado: (2016)

Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults
por: Fey, Constanze, et al.
Publicado: (2014)

Formulation of metoclopramide HCl gastroretentive film and in vitro- in silico prediction using Gastroplus® PBPK software
por: Safaa Hamdi, Dalia, et al.
Publicado: (2022)

Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling.
por: Yang, R S, et al.
Publicado: (1998)

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients
por: Kovar, Lukas, et al.
Publicado: (2020)

Use of PBPK Modeling To Evaluate the Performance of DissolvIt, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products
por: Hassoun, Mireille, et al.
Publicado: (2019)

Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
por: Frechen, Sebastian, et al.
Publicado: (2022)

Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling
por: Grañana-Castillo, Sandra, et al.
Publicado: (2022)

Formulation and evalution of montelukast sodium - chitosan based spray dried microspheres for pulmonary drug delivery
por: Panchal, Rushi, et al.
Publicado: (2012)

Fabricating transdermal film formulations of montelukast sodium with improved chemical stability and extended drug release
por: Aashli, et al.
Publicado: (2023)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
por: Scaparrotta, Alessandra, et al.
Publicado: (2012)

Probable montelukast-induced hepatotoxicity in a pediatric patient: case report
por: Incecik, Faruk, et al.
Publicado: (2007)

PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Kidney in Pregnant Subjects and Fetus
por: Szeto, Ke Xu, et al.
Publicado: (2021)

A Workflow for Global Sensitivity Analysis of PBPK Models
por: McNally, Kevin, et al.
Publicado: (2011)

PBPK Modeling on Organs-on-Chips: An Overview of Recent Advancements
por: Yang, Yi, et al.
Publicado: (2022)

Permeability of Gemcitabine and PBPK Modeling to Assess Oral Administration
por: Ferreira, Abigail, et al.
Publicado: (2021)

Effects of Montelukast in an Experimental Model of Acute Pancreatitis
por: Angı, Serkan, et al.
Publicado: (2016)

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
por: Freriksen, Jolien J. M., et al.
Publicado: (2022)

Montelukast in the management of allergic rhinitis
por: Lagos, Jaime A, et al.
Publicado: (2007)

PBPK Model for Atrazine and Its Chlorotriazine Metabolites in Rat and Human
por: Campbell, Jerry L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lqarfdmg4gbmumuo3kdtk9f95e